Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SULT1E1 | P49888 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | TTL | Q8NG68 | 1/20 | 0.31 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.30 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.30 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.30 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.30 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.30 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.30 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.30 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2784576 | 0.83 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL26472020 | 0.83 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL4456739 | 0.79 | ALDH1A1 (0.60) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446725 | 0.76 | ALDH1A1 (1.00) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL17301626 | 0.73 | ALDH1A1 (0.50) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL4451477 | 0.71 | SULT1E1 (0.59) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL26472022 | 0.70 | ALDH1A1 (0.53) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| Marrubenol SCHEMBL4450048 | 0.69 | ALDH1A1 (0.53) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446720 | 0.69 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446726 | 0.69 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997045099-A1 | USE OF LABDANUM FURANOID DITERPENOIDS FOR PREPARING COSMETIC OR PHARMACEUTICAL AND SKIN CELL CULTURE MEDIA COMPOSITIONS | LVMH RECHERCHE (FR) | 1997-12-04 | — | — | WO | claimed |
| US-8865229-B2 | Marrubiin and composition for reducing snoring, package and method | PURANOX MEDICAL B.V. (NL) | 2014-10-21 | — | — | US | disclosed |
| US-20110305780-A1 | Marrubiin and composition for reducing snoring, package and method | PURANOX MEDICAL B.V. (NL) | 2011-12-15 | — | — | US | disclosed |
| EP-1915166-B1 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | PURANOX MEDICAL B V (NL) | 2009-05-20 | — | — | EP | disclosed |
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | PURANOX MEDICAL B.V. (NL) | 2008-12-11 | — | — | US | disclosed |
| EP-1915166-A2 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | Puranox Medical B.V. (NL) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007018432-A2 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | PURANOX MEDICAL B.V. (NL) | 2007-02-15 | — | — | WO | disclosed |
| WO-1997045099-A1 | USE OF LABDANUM FURANOID DITERPENOIDS FOR PREPARING COSMETIC OR PHARMACEUTICAL AND SKIN CELL CULTURE MEDIA COMPOSITIONS | LVMH RECHERCHE (FR) | 1997-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | NISCH, UTRN, MTPN | ALDH1A1 1660/4885MAPT 4300/4885USP2 3949/4885 |
| US-20110305780-A1 | Marrubiin and composition for reducing snoring, package and method | NISCH, UTRN, MTPN | ALDH1A1 1738/4885MAPT 4275/4885USP2 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.